Skip to main content
Retour
Watch Compare

Cardiff Lexington Corp

Qualité des données : 83%
CDIX
OTC Services Health Services
1,88 €
▼ 0,54 € (-22,22%)
Cap. Boursière: 36,64 M
Prix
2,42 €
Cap. Boursière
36,64 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue grew 3,61% annually over 5 years — modest growth
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 35,87%
ROIC of 15,19% — excellent capital efficiency
Interest coverage of 0,16× — tight debt servicing

Croissance

Revenue Growth (5Y)
3,61%
En dessous de la moyenne du secteur (4,21%)
Revenue (1Y)39,48%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-2830,40%
En dessous de la moyenne du secteur (-15,99%)
ROIC15,19%
Net Margin-47,74%
Op. Margin9,54%

Sécurité

Debt / Equity
N/A
Current Ratio0,94
Interest Coverage0,16

Valorisation

PE (TTM)
-6,65
En dessous de la moyenne du secteur (-1,17)
P/B RatioN/A
EV/EBITDA46,74
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (515 pairs)
Métrique Action Médiane du Secteur
P/E -6,7 -1,2
P/B — 1,4
ROE % -2830,4 -16,0
Net Margin % -47,7 -19,4
Rev Growth 5Y % 3,6 4,2
D/E — 0,4

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2026 — 11,95 M —

All Fundamental Metrics
Growth
Revenue Growth (1Y) 39,48% Revenue Growth (3Y) -1,35%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 3,61% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 11,54 M Net Income (TTM) -5,51 M
ROE -2830,40% ROA -20,35%
Gross Margin 62,47% Operating Margin 9,54%
Net Margin -47,74% Free Cash Flow (TTM) N/A
ROIC 15,19% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,94
Interest Coverage 0,16 Asset Turnover 0,43
Working Capital -1,34 M Tangible Book Value -6,03 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6,65 Forward P/E N/A
P/B Ratio N/A P/S Ratio 3,18
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 46,74 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap 36,64 M Enterprise Value 51,71 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,76
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum 35,87

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 11,54 M 8,27 M 11,85 M 12,00 M 10,01 M
Net Income -5,51 M -3,30 M 3,03 M -5,43 M -409 707,0
EPS (Diluted) — — — -0,01 —
Gross Profit 7,21 M 4,43 M 8,29 M 7,54 M 6,16 M
Operating Income 1,10 M -193 504,0 5,20 M 1,69 M 1,63 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses 5,33 M 4,06 M 3,08 M 3,73 M 4,52 M
D&A 5 652,0 13 461,0 20 777,0 23 131,0 35 334,0
Interest Expense 6,82 M — 439 618,0 452 864,0 —
Income Tax 0,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 29,09 M 23,93 M 20,75 M 13,35 M 11,16 M
Total Liabilities 26,01 M 16,32 M 14,12 M 10,20 M 8,38 M
Shareholders' Equity -2,47 M 2,69 M 731 418,0 -1,47 M 2,78 M
Total Debt 18,56 M 9,21 M 2,28 M 155 598,0 600 932,0
Cash & Equivalents — — — — —
Current Assets 22,59 M 17,21 M 14,18 M 6,84 M 5,55 M
Current Liabilities 25,83 M 15,89 M 13,86 M 9,97 M 8,11 M